WLY icon

John Wiley & Sons Class A

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 72.7%
Negative

Neutral
Business Wire
21 days ago
Wiley Announces Quarterly Dividend; Allocated $126 million to Dividends and Repurchases in 9 Months of Fiscal 2026
HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that its Board of Directors has declared a quarterly cash dividend of $0.355 per share on its Class A and Class B Common Stock, payable on April 23, 2026, to shareholders of record on April 7, 2026. The quarterly dividend is equivalent to an annual dividend of $1.42 per share, an increase from.
Wiley Announces Quarterly Dividend; Allocated $126 million to Dividends and Repurchases in 9 Months of Fiscal 2026
Neutral
Seeking Alpha
1 month ago
John Wiley & Sons, Inc. (WLY) Q3 2026 Earnings Call Transcript
John Wiley & Sons, Inc. (WLY) Q3 2026 Earnings Call Transcript
John Wiley & Sons, Inc. (WLY) Q3 2026 Earnings Call Transcript
Neutral
Business Wire
1 month ago
AI Momentum, Material Margin Expansion, and Cash Flow Growth Highlight Wiley's Third Quarter 2026
HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the third quarter ended January 31, 2026. THIRD QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $410 million up 1%; Operating Income of $63 million up 21%; and Diluted Earnings Per Share (EPS) of $0.56 compared to prior year loss of ($0.43) Adjusted Results at constant c.
AI Momentum, Material Margin Expansion, and Cash Flow Growth Highlight Wiley's Third Quarter 2026
Neutral
Business Wire
1 month ago
Wiley and OpenEvidence Partner to Deliver Trusted Research to Physicians at the Point of Care
HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of clinical practice, scientific discovery and learning, and OpenEvidence, the most widely used medical AI platform in the world, today announced a strategic partnership to bring Wiley's trusted scientific and medical content into OpenEvidence. Through the partnership, physicians using OpenEvidence at the point of care can rely on content from hundreds of Wil.
Wiley and OpenEvidence Partner to Deliver Trusted Research to Physicians at the Point of Care
Neutral
Business Wire
1 month ago
Wiley Schedules Third Quarter 2026 Earnings Release and Conference Call
HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY and WLYB), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its third quarter 2026 results prior to market open on Thursday March 5, 2026. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at http://events.q4inc.com/attendee/46.
Wiley Schedules Third Quarter 2026 Earnings Release and Conference Call
Positive
Zacks Investment Research
1 month ago
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does John Wiley & Sons (WLY) have what it takes?
Are You Looking for a High-Growth Dividend Stock?
Neutral
Seeking Alpha
1 month ago
John Wiley & Sons: Structural Risk To Higher Education Casts A Shadow Over AI Licensing
John Wiley & Sons delivers solid margin improvement and research sales growth, aided by high-margin AI licensing revenues. WLY faces structural headwinds in its learning segment due to weak white-collar job markets and potential long-term enrollment declines from LLM disruption. Despite mixed segment performance, WLY maintains strong FCF generation, robust buybacks, and a combined yield near 13% after recent price declines.
John Wiley & Sons: Structural Risk To Higher Education Casts A Shadow Over AI Licensing
Neutral
Business Wire
1 month ago
Wiley to Expand Prestigious Advanced Journals Portfolio
HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley to significantly expand the Advanced Portfolio into life, health, and social sciences disciplines, launching eight new journals in 2026.
Wiley to Expand Prestigious Advanced Journals Portfolio
Neutral
PRNewsWire
2 months ago
Virtusa and Wiley Form a Multi-Year Partnership to Accelerate Wiley's Technology Transformation
SOUTHBOROUGH, Mass., Feb. 10, 2026 /PRNewswire/ -- Virtusa Corporation, a global leader in digital business strategy and AI-led product and platform engineering, and Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced a multi-year managed services partnership under which Virtusa will provide infrastructure and application services and support Wiley's strategic technology initiatives.
Virtusa and Wiley Form a Multi-Year Partnership to Accelerate Wiley's Technology Transformation
Positive
Zacks Investment Research
2 months ago
Why John Wiley & Sons (WLY) is a Great Dividend Stock Right Now
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does John Wiley & Sons (WLY) have what it takes?
Why John Wiley & Sons (WLY) is a Great Dividend Stock Right Now